DOLAMA 200: Effectiveness and Safety of a Dual Therapy with Dolutegravir Plus Lamivudine in Treatment-Experienced HIV-1 Infected Real World Participants in Spain

Colaboración

Año: 2024

Sequera-Arquelladas, S; Hidalgo-Tenorio, C; Lopez-Cortés, L; Gutiérrez, A; Santos, J; Téllez, F; Omar, M; Ferra-Murcia, S; Fernández, E; Javier, R; García-Vallecillos, C; Pasquau, J

Título: VIRUSES-BASEL

• Q2